| ATMP | Advanced therapeutic medicinal product |
| BM | Bone marrow |
| CBT | Cord blood transplantation |
| DMSO | Dimethyl sulfoxide |
| DT | Doubling time |
| EBMT | European Group for Blood and Marrow Transplantation |
| EP | European pharmacopeia |
| FBS | Fetal bovine serum |
| FDA | Food and drug administration |
| FIFO | First-in first-out |
| GMP | Good manufacturing practice |
| GVHD | Graft versus host disease |
| HCT | Hematopoietic cell transplantation |
| HPL | Human platelet lysate |
| HSA | Human serum albumin |
| IDO | Indolamine oxidase |
| IFNγ | Interferon gamma |
| ISBT | International society of blood transfusion |
| ISCT | International Society of Cellular Therapy |
| IQ | Installation qualification |
| IV | Intravenous |
| LTCG | Laboratory of Cell and Gene Therapy |
| MLR | Mixed Lymphocyte Reaction |
| MSC | Mesenchymal stem/stromal cells |
| NaCl | Sodium chloride |
| NAT | Nucleic amplification technique |
| OQ | Operational qualification |
| PBMC | Peripheral blood mononuclear cells |
| PDL | Population doubling level |
| PDL-1 | Programmed death ligand 1 |
| PQ | Performance qualification |
| QA | Quality assurance |
| QC | Quality control |
| QP | Qualified person |
| SCM | Serum-containing media |
| SFM | Serum-free media |
| SOP | Standard operating procedure |
| TSE | Transmission of spongiform encephalopathy |
| URS | User-specific specifications |